Clinical Trial: L9LS in Women of Childbearing Potential in Mali

U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060508) titled 'L9LS in Women of Childbearing Potential in Mali' on June 10.

Brief Summary: Safety and Efficacy of L9LS, a Human Monoclonal Antibody Against Plasmodium falciparum, in a Randomized, Double-Blind, Placebo-Controlled Trial of Women of Childbearing Potential (WOCBP) in Mali

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Malaria

Intervention: BIOLOGICAL: Single dose of 1800 mg L9LS SC

A human monoclonal antibody to protect against Plasmodium falciparum.

OTHER: Placebo

Normal saline

Recruitment Status: NOT_YET_RECRUITING

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Disclaimer: Cura...